Alex Belser is a psychologist and psychedelic researcher in clinical trials at NYU and Yale University. He is also a co-founder of the psychedelic research group at NYU.  He studied at Georgetown University, the University of Cambridge, Columbia University, NYU, and Yale University. He is the Chief Clinical Officer of Cybin, and served as Chief Clinical Officer at Adelia Therapeutics. Additionally, he is a member of Chacruna Institute’s Women, Gender Diversity, and Sexual Minorities Working Group.  He has investigated psilocybin and MDMA to treat depression, anxiety, substance use, OCD, PTSD, and end-of-life distress. He is co-author of EMBARK, a psychedelic-assisted psychotherapy model, and was a contributor to Psychedelic Justice: Toward a Diverse and Equitable Psychedelic Culture, (Synergetic Press, 2021).